1. Home
  2. ALMS vs MAGN Comparison

ALMS vs MAGN Comparison

Compare ALMS & MAGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALMS
  • MAGN
  • Stock Information
  • Founded
  • ALMS 2021
  • MAGN 1864
  • Country
  • ALMS United States
  • MAGN United States
  • Employees
  • ALMS N/A
  • MAGN N/A
  • Industry
  • ALMS
  • MAGN Paper
  • Sector
  • ALMS
  • MAGN Basic Materials
  • Exchange
  • ALMS NYSE
  • MAGN Nasdaq
  • Market Cap
  • ALMS 402.6M
  • MAGN 442.9M
  • IPO Year
  • ALMS 2024
  • MAGN N/A
  • Fundamental
  • Price
  • ALMS $3.52
  • MAGN $13.28
  • Analyst Decision
  • ALMS Strong Buy
  • MAGN Hold
  • Analyst Count
  • ALMS 7
  • MAGN 1
  • Target Price
  • ALMS $24.50
  • MAGN $16.00
  • AVG Volume (30 Days)
  • ALMS 841.5K
  • MAGN 951.1K
  • Earning Date
  • ALMS 08-12-2025
  • MAGN 08-15-2025
  • Dividend Yield
  • ALMS N/A
  • MAGN N/A
  • EPS Growth
  • ALMS N/A
  • MAGN N/A
  • EPS
  • ALMS N/A
  • MAGN N/A
  • Revenue
  • ALMS $17,389,000.00
  • MAGN $2,636,000,000.00
  • Revenue This Year
  • ALMS N/A
  • MAGN $47.87
  • Revenue Next Year
  • ALMS N/A
  • MAGN $4.76
  • P/E Ratio
  • ALMS N/A
  • MAGN N/A
  • Revenue Growth
  • ALMS N/A
  • MAGN 15.87
  • 52 Week Low
  • ALMS $2.76
  • MAGN $11.43
  • 52 Week High
  • ALMS $13.50
  • MAGN $26.78
  • Technical
  • Relative Strength Index (RSI)
  • ALMS N/A
  • MAGN N/A
  • Support Level
  • ALMS N/A
  • MAGN N/A
  • Resistance Level
  • ALMS N/A
  • MAGN N/A
  • Average True Range (ATR)
  • ALMS 0.00
  • MAGN 0.00
  • MACD
  • ALMS 0.00
  • MAGN 0.00
  • Stochastic Oscillator
  • ALMS 0.00
  • MAGN 0.00

About ALMS ALUMIS INC

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.

About MAGN Magnera Corporation Common Stock

Magnera Corp formerly Glatfelter Corporation manufactures and sells a variety of paper and fiber products. The company's reportable segments are; Composite Fibers, Spunlace. and Airlaid Materials. The Airlaid Materials segment which is also its key revenue generating segment, is a supplier of cellulose-based airlaid nonwoven materials used to manufacture consumer products for end-user markets. The Airlaid Materials segment produces materials used in feminine hygiene, specialty wipes, tabletop, home care, and other consumables. Geographically, the company derives majority of its revenue from Americas and rest from Europe, Middle East, Africa and Asia Pacific markets.

Share on Social Networks: